ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » Neurology

Top Neurology Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER TODD MD

Neurology

132

$10.6K

13
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $293

WILLIAM DAUER M.D.

Neurology

141

$9,174

24
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $293

MOHAMMAD IBRAHIM MD

Neurology

179

$9,030

23
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

0%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $293

KAMAL SADJADPOUR M.D.

Neurology

185

$119K

32
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 24%

$643
Average prescription price

Avg: $293

DEEPTI ZUTSHI M.D.

Neurology

206

$60K

33
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$291
Average prescription price

Avg: $293

DANIEL LEVENTHAL MD

Neurology

214

$34.4K

28
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$161
Average prescription price

Avg: $293

JEFFREY HALLADAY M.D.

Neurology

215

$250K

37
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$1164
Average prescription price

Avg: $293

ARUN CHANDOK M.D.

Neurology

227

$21.2K

35
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $293

ANGELOS KATRAMADOS MD

Neurology

253

$30.2K

61
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $293

TRICOUNTY NEUROLOGICAL ASSOC

Neurology

289

$130K

26
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$451
Average prescription price

Avg: $293

VIKAS KOTAGAL MD

Neurology

289

$52K

57
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $293

NAGANAND SRIPATHI M.D.

Neurology

294

$16.6K

50
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $293

AMY PAPPAS D.O.

Neurology

297

$22.8K

93
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $293

CARA LEAHY D.O.

Neurology

305

$42.4K

51
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $293

HALA NAHHAS M.D.

Neurology

340

$21.3K

87
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $293

TAAS KING D.O

Neurology

346

$22.5K

58
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $293

KRISTINA KARANEC DO

Neurology

358

$58K

43
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $293

BRIAN KIRSCHNER MD

Neurology

376

$169K

94
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$448
Average prescription price

Avg: $293

MARY SHAYA M.D.

Neurology

383

$33.6K

56
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $293

JACK PARENT MD

Neurology

395

$29.9K

24
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $293

MARY ANN MCKEE M.D.

Neurology

409

$33.6K

71
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $293

JOSHUA ADLER MD PHD

Neurology

419

$68.6K

59
13 are 65+

32%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 5%

14%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$164
Average prescription price

Avg: $293

KAVITA GROVER M.D.

Neurology

427

$321K

71
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$751
Average prescription price

Avg: $293

GERALD ROBBINS D.O.

Neurology

428

$57K

75
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $293

ERIC EGGENBERGER D.O

Neurology

430

$580K

46
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 5%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$1349
Average prescription price

Avg: $293

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank